Product
LLV
1 clinical trial
1 indication
Indication
Pancreatic AdenocarcinomaClinical trial
A Single-arm Multicentre Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Who Have Not Previously Received Therapy for Metastatic Adenocarcinoma of the PancreasStatus: Not yet recruiting, Estimated PCD: 2025-08-28